CD8A and neoplasm: Compared to a single modality treatment, this approach has been shown to improve tumor control via a variety of mechanisms, including immune priming, release of tumor-specific antigens, and generation/maturation of CD8+ T cells in the tumor microenvironment [11,41,42,43].